Organigram Holdings Inc. (OGI) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Organigram Holdings Inc. (OGI:NASDAQ), powered by AI.

Current Price
$1.01
P/E Ratio
-5.2
Market Cap
129M
Sector
Healthcare
What is the Organigram Holdings Inc. stock price forecast?

Organigram Holdings Inc. is currently trading at $1.01. View real-time AI analysis on Alpha Lenz.

What is Organigram Holdings Inc. insider trading activity?

View the latest insider trading data for Organigram Holdings Inc. on Alpha Lenz.

What is Organigram Holdings Inc.'s P/E ratio?

Organigram Holdings Inc.'s P/E ratio is -5.2.

Organigram Holdings Inc.

NASDAQ · OGI
$1.01-0.02(-1.94%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Organigram Holdings Inc.'s future dividend policy...
Alpha Chat Insight

Organigram Holdings Inc. trades at a P/E of -5.2 (undervalued) with modest ROE of -8.7%. 3Y revenue CAGR of 21.1% highlights clear growth momentum.

Ask for details

Company Overview

Organigram Holdings Inc. is a Canadian company focused on the cannabis industry, primarily engaged in producing and selling cannabis and cannabis-derived products. Its primary function is to cater to both the medical and adult-use cannabis markets, offering a diverse range of products including dried flower, pre-rolls, edibles, and vape oils. Organigram is known for its innovative approach to cultivation, leveraging advanced technologies and facilities to ensure high-quality and consistent product offerings. The company impacts various sectors, notably pharmaceuticals, consumer goods, and wellness markets, as it capitalizes on the expanding legalization and increasing demand for cannabis products. As a significant player in the North American cannabis market, Organigram positions itself strategically with its multi-faceted brand portfolio, aiming to appeal to a broad demographic by addressing both medicinal and recreational needs. Headquartered in Moncton, New Brunswick, Organigram Holdings Inc. has a substantial market role as it contributes to the evolving cannabis landscape, navigating regulatory challenges and participating in significant industry developments. Its efforts in research and product innovation underscore its influence and commitment to growth in the dynamic cannabis sector.

CEOMs. Beena G. Goldenberg
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees1,178

Company Statistics

FY 2025

Profile

$128.95MMarket Cap
$259.18MRevenue
0.00Shares Out
1,178Employees

Margins

34.81%Gross
9.98%EBITDA
-5.90%Operating
-14.87%Pre-Tax
-9.55%Net

Valuation

-5.21P/E
0.37P/B
0.50EV/Sales
4.23EV/EBITDA
-5.23P/FCF

Growth (CAGR)

21.14%Rev 3Yr
24.46%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-5.77%ROA
-8.67%ROE
-3.57%ROIC

Financial Health

$28.20MCash & Cash Equivalents
$184.88MNet Debt
61.03%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Organigram Holdings Inc. (ticker: OGI) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 1,178 employees. Market cap is $129M.

The current price is $1.01 with a P/E ratio of -5.21x and P/B of 0.37x.

ROE is -8.67% and operating margin is -5.90%. Annual revenue is $259M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Organigram Holdings Inc. (OGI) Stock Forecast 2026 $1.01 — Price, Financials & Analyst Targets | Alpha Lenz